{"log_id": 5577172077519222925, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 0.002202, "average": 0.981158, "min": 0.848662}, "location": {"width": 158, "top": 237, "height": 29, "left": 243}, "words": "最大值>1倍ULN"}, {"probability": {"variance": 0.003869, "average": 0.972907, "min": 0.820604}, "location": {"width": 155, "top": 243, "height": 30, "left": 546}, "words": "408.941"}, {"probability": {"variance": 0, "average": 0.984003, "min": 0.984003}, "location": {"width": 17, "top": 249, "height": 22, "left": 756}, "words": "8"}, {"probability": {"variance": 3e-06, "average": 0.998461, "min": 0.994723}, "location": {"width": 166, "top": 249, "height": 26, "left": 844}, "words": "338.935"}, {"probability": {"variance": 0.000271, "average": 0.984703, "min": 0.951728}, "location": {"width": 81, "top": 288, "height": 25, "left": 309}, "words": ">2倍ULN"}, {"probability": {"variance": 4e-06, "average": 0.998239, "min": 0.994355}, "location": {"width": 112, "top": 292, "height": 21, "left": 452}, "words": "4.921"}, {"probability": {"variance": 0, "average": 0.999539, "min": 0.999465}, "location": {"width": 26, "top": 292, "height": 26, "left": 680}, "words": "22"}, {"probability": {"variance": 4.7e-05, "average": 0.994545, "min": 0.979108}, "location": {"width": 163, "top": 297, "height": 24, "left": 846}, "words": "143.112"}, {"probability": {"variance": 0.000104, "average": 0.993559, "min": 0.971628}, "location": {"width": 89, "top": 333, "height": 24, "left": 306}, "words": ">4倍ULN"}, {"probability": {"variance": 0.001255, "average": 0.978989, "min": 0.884327}, "location": {"width": 174, "top": 378, "height": 28, "left": 307}, "words": ">5倍ULN1.4"}, {"probability": {"variance": 0.001493, "average": 0.930239, "min": 0.892709}, "location": {"width": 39, "top": 389, "height": 22, "left": 909}, "words": "0.0"}, {"probability": {"variance": 0.000393, "average": 0.988011, "min": 0.938989}, "location": {"width": 182, "top": 424, "height": 25, "left": 306}, "words": ">10倍ULN0.5"}, {"probability": {"variance": 7.5e-05, "average": 0.987169, "min": 0.978495}, "location": {"width": 19, "top": 430, "height": 22, "left": 606}, "words": "0."}, {"probability": {"variance": 2.8e-05, "average": 0.995693, "min": 0.988264}, "location": {"width": 41, "top": 433, "height": 21, "left": 752}, "words": "0.2"}, {"probability": {"variance": 7.2e-05, "average": 0.991143, "min": 0.976552}, "location": {"width": 99, "top": 435, "height": 24, "left": 908}, "words": "0.00"}, {"probability": {"variance": 8.8e-05, "average": 0.995769, "min": 0.946218}, "location": {"width": 791, "top": 464, "height": 46, "left": 226}, "words": "注意:在用本品或对照药治疗的患者中观察到的CPK升高无临床或统计学显著性"}, {"probability": {"variance": 0, "average": 0.999576, "min": 0.999355}, "location": {"width": 48, "top": 512, "height": 27, "left": 227}, "words": "差异"}, {"probability": {"variance": 0.006822, "average": 0.974195, "min": 0.601388}, "location": {"width": 792, "top": 555, "height": 44, "left": 224}, "words": "注:a.对照药;万古霉素(每12小时静脉给药1g)或抗葡萄球菌的半合成青霉素"}, {"probability": {"variance": 0.001477, "average": 0.984552, "min": 0.77636}, "location": {"width": 793, "top": 599, "height": 44, "left": 223}, "words": "类(即萘夫西林、苯唑西林、氯唑西林或氟氯西林;每日4~12g分次静脉给药)"}, {"probability": {"variance": 0.008886, "average": 0.973668, "min": 0.563298}, "location": {"width": 366, "top": 647, "height": 29, "left": 257}, "words": "b.UN(正常值上限)定义为200U/L"}, {"probability": {"variance": 0.004016, "average": 0.974908, "min": 0.653245}, "location": {"width": 740, "top": 689, "height": 42, "left": 268}, "words": "在cSSS中国患者Ⅲ期临床试验中,本品组4/131(3.1%)例患者出现血CPK"}, {"probability": {"variance": 3.8e-05, "average": 0.996438, "min": 0.970706}, "location": {"width": 789, "top": 732, "height": 42, "left": 222}, "words": "升高,对照药物组没有发生该事件。该4名患者基线时CPK正常,其中1例(0.8%)"}, {"probability": {"variance": 0.003444, "average": 0.982776, "min": 0.651332}, "location": {"width": 790, "top": 775, "height": 46, "left": 221}, "words": "患者在治疗结束后CPK升高>10倍ULN,治愈检验时CPK回落到正常值,另外3例"}, {"probability": {"variance": 0.000187, "average": 0.990046, "min": 0.942485}, "location": {"width": 284, "top": 822, "height": 33, "left": 239}, "words": "2.3%)患者CPK升高<2倍ULN"}, {"probability": {"variance": 5.4e-05, "average": 0.996237, "min": 0.974722}, "location": {"width": 380, "top": 866, "height": 37, "left": 265}, "words": "金黄色葡萄球菌菌血症/心内膜炎试验"}, {"probability": {"variance": 0.006776, "average": 0.97133, "min": 0.580845}, "location": {"width": 788, "top": 912, "height": 42, "left": 264}, "words": "在本品用药剂量为6mg/kg的金黄色葡萄球菌菌血症/心内膜炎试验中,"}, {"probability": {"variance": 0.004236, "average": 0.977512, "min": 0.569013}, "location": {"width": 794, "top": 955, "height": 44, "left": 217}, "words": "11/120(9.2%)例接受本品治疗的患者CPK升高到>500U/L,包括2例基线CPK"}, {"probability": {"variance": 0.001376, "average": 0.984115, "min": 0.83182}, "location": {"width": 778, "top": 999, "height": 45, "left": 217}, "words": "水平>500U/L的患者,而1/16(0.9%)例以对照药治疗的患者发生了上述事件"}, {"probability": {"variance": 0.004295, "average": 0.983265, "min": 0.599006}, "location": {"width": 821, "top": 1041, "height": 51, "left": 217}, "words": "在这11例本品治疗的患者中,4例患者先前曾使用过或伴随使用羟甲基戊二酰辅"}, {"probability": {"variance": 0.009666, "average": 0.963947, "min": 0.488923}, "location": {"width": 792, "top": 1090, "height": 43, "left": 215}, "words": "酶A(HMG-COA)还原酶抑制剂进行治疗,3例患者因CPK升高而停用本品,而1例"}, {"probability": {"variance": 1e-06, "average": 0.999172, "min": 0.996218}, "location": {"width": 323, "top": 1135, "height": 33, "left": 214}, "words": "对照药治疗的患者没有中止治疗"}, {"probability": {"variance": 9e-06, "average": 0.99652, "min": 0.991122}, "location": {"width": 155, "top": 1181, "height": 27, "left": 258}, "words": "2、上市后经验"}, {"probability": {"variance": 0.001707, "average": 0.990211, "min": 0.76374}, "location": {"width": 747, "top": 1222, "height": 44, "left": 259}, "words": "以下为本品获得上市批准后在使用中的不良反应。由于这些反应是由数量不"}, {"probability": {"variance": 7e-06, "average": 0.997818, "min": 0.990566}, "location": {"width": 794, "top": 1267, "height": 43, "left": 211}, "words": "定的人群中自发报告的,故无法可靠地估算其发生率或确立这些事件与药物暴露"}, {"probability": {"variance": 1.4e-05, "average": 0.995911, "min": 0.990681}, "location": {"width": 117, "top": 1312, "height": 28, "left": 212}, "words": "的因果关系"}, {"probability": {"variance": 1e-06, "average": 0.999253, "min": 0.994889}, "location": {"width": 748, "top": 1358, "height": 42, "left": 255}, "words": "免疫系统:速发型过敏反应及超敏反应,包括瘙痒、荨麻疹、呼吸急促、吞"}, {"probability": {"variance": 0.012241, "average": 0.967983, "min": 0.540008}, "location": {"width": 370, "top": 1402, "height": 35, "left": 209}, "words": "咽困难、躯干红斑、肺嗜酸细胞增多"}, {"probability": {"variance": 1.3e-05, "average": 0.998473, "min": 0.985203}, "location": {"width": 345, "top": 1448, "height": 33, "left": 255}, "words": "感染及侵染:艰难梭菌相关性腹泻"}, {"probability": {"variance": 0.000313, "average": 0.993834, "min": 0.905312}, "location": {"width": 749, "top": 1491, "height": 44, "left": 253}, "words": "肌肉骨骼系统:肌红蛋白升离、横纹肌溶解(一些报告来自同时接受本品和"}, {"probability": {"variance": 0.004946, "average": 0.980335, "min": 0.614235}, "location": {"width": 605, "top": 1534, "height": 41, "left": 206}, "words": "羟甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂治疗的患者);"}], "language": 3}